Philip Louis Felgner (born 7 February 1950) is an American biochemists and immunologists, specialized in lipofection technology and genetics. He is one of the developers of the vaccine against the SARS-CoV-2 virus, responsible for COVID-19 pandemic.
Philip Felgner | |
---|---|
Born | Philip Louis Felgner 7 February 1950 Frankenmuth, Michigan, United States |
Alma mater | Michigan State University |
Scientific career | |
Fields |
In 1972, he graduated in biochemistry from the Michigan State University, earning his master's degree in 1975 and his Ph.D. in 1978. He did postdoctoral work at the University of Virginia.[1]
In 2021, he was awarded the Princess of Asturias Awards for Technical and Scientific Research along Katalin Karikó, Drew Weissman, Uğur Şahin, Özlem Türeci, Derrick Rossi, and Sarah Gilbert.[2]
References
edit